Smoking status and risk for recurrent coronary events after myocardial infarction.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 12230350)

Published in Ann Intern Med on September 17, 2002

Authors

Thomas D Rea1, Susan R Heckbert, Robert C Kaplan, Nicholas L Smith, Rozenn N Lemaitre, Bruce M Psaty

Author Affiliations

1: University of Washington, Cardiovascular Health Research Unit, Metropolitan Park, East Tower, 1730 Minor Avenue, Suite 1360, Seattle, WA 98101, USA. rea123@u.washington.edu

Associated clinical trials:

Antihypertensive Drug/Gene Interactions and CV Events | NCT00005332

Articles citing this

Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome. Hum Mol Genet (2012) 2.24

A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality. Multivariate Behav Res (2011) 2.06

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation (2009) 1.77

Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Hum Genet (2013) 1.43

Care following acute myocardial infarction in the Veterans Administration Medical Centers: a comparison with Medicare. Health Serv Res (2004) 1.31

Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study. BMJ (2012) 1.00

Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol (2014) 0.98

Distress related to myocardial infarction and cardiovascular outcome: a retrospective observational study. BMC Psychiatry (2011) 0.93

Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6-9 years excess risk in individuals with familial hypercholesterolemia. BMC Public Health (2006) 0.92

Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol (2007) 0.87

Smoking and cardiac rehabilitation participation: Associations with referral, attendance and adherence. Prev Med (2015) 0.86

The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients. J Behav Med (2009) 0.86

Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes (2015) 0.83

Genome-Wide Analysis of DNA Methylation and Cigarette Smoking in a Chinese Population. Environ Health Perspect (2016) 0.80

Changes in smoking behavior and adherence to preventive guidelines among smokers after a heart attack. J Geriatr Cardiol (2013) 0.79

CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction. Nicotine Tob Res (2014) 0.76

Predictive and Prognostic Value of High-density Lipoprotein Cholesterol in Young Male Patients with Acute Myocardial Infarction. Chin Med J (Engl) (2017) 0.75

[Low success rate of smoking cessation in the short to medium term at the waning of an acute myocardial infarction in a cardiology department in Dakar, Senegal]. Pan Afr Med J (2011) 0.75

Impact of Broadened Coverage of Smoking Cessation Treatments on Cardiovascular Disease. Curr Cardiovasc Risk Rep (2012) 0.75

Associations of Depressive Symptoms and Brachial Artery Reactivity among Police Officers. Saf Health Work (2013) 0.75

Smoking cessation and outcome after ischemic stroke or TIA. Neurology (2017) 0.75

Articles by these authors

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (2003) 8.64

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47

Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA (2012) 5.41

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol (2006) 5.28

Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20

Inflammation as a risk factor for atrial fibrillation. Circulation (2003) 4.95

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.61

Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med (2004) 4.38

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

Antibiotic use in relation to the risk of breast cancer. JAMA (2004) 4.28

Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.10

Personalized medicine in the era of genomics. JAMA (2007) 4.02

Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97

Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93

Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med (2006) 3.91

Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet (2009) 3.80

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation (2003) 3.76

Genome-wide association study of PR interval. Nat Genet (2010) 3.73

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73

Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet (2012) 3.71

Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68

Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55

Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol (2004) 3.53

Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50

Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA (2007) 3.50

Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA (2006) 3.26

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium. PLoS Genet (2009) 3.18

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med (2002) 3.15

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10

LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2007) 3.08

Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet (2011) 3.07

The landscape of recombination in African Americans. Nature (2011) 3.06

Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care (2009) 3.06

Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med (2010) 3.05

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03

Genetic associations with valvular calcification and aortic stenosis. N Engl J Med (2013) 3.02

Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation (2007) 2.93

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92